SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
12352386
Source:
http://linkedlifedata.com/resource/pubmed/id/12352386
Search
Subject
(
59
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0036043
,
umls-concept:C0087111
,
umls-concept:C0242350
,
umls-concept:C0936012
,
umls-concept:C1176316
,
umls-concept:C1274040
pubmed:issue
4 Pt 1
pubmed:dateCreated
2002-9-27
pubmed:abstractText
We conducted integrated analyses of the efficacy and safety of tadalafil, a potent, selective phosphodiesterase 5 inhibitor, for the treatment of erectile dysfunction.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/12352386
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0376374
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/3',5'-Cyclic-GMP Phosphodiesterases
,
http://linkedlifedata.com/resource/pubmed/chemical/Carbolines
,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclic Nucleotide...
,
http://linkedlifedata.com/resource/pubmed/chemical/PDE5A protein, human
,
http://linkedlifedata.com/resource/pubmed/chemical/Phosphodiesterase Inhibitors
,
http://linkedlifedata.com/resource/pubmed/chemical/Phosphoric Diester Hydrolases
,
http://linkedlifedata.com/resource/pubmed/chemical/tadalafil
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0022-5347
pubmed:author
pubmed-author:AnglinGregG
,
pubmed-author:BrockGerald BGB
,
pubmed-author:ChenK KKK
,
pubmed-author:CostiganTimothyT
,
pubmed-author:McMahonChris GCG
,
pubmed-author:ShenWeiW
,
pubmed-author:WatkinsVishV
,
pubmed-author:WhitakerSteveS
pubmed:issnType
Print
pubmed:volume
168
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1332-6
pubmed:dateRevised
2009-7-20
pubmed:meshHeading
pubmed-meshheading:12352386-3',5'-Cyclic-GMP Phosphodiesterases
,
pubmed-meshheading:12352386-Adult
,
pubmed-meshheading:12352386-Aged
,
pubmed-meshheading:12352386-Aged, 80 and over
,
pubmed-meshheading:12352386-Carbolines
,
pubmed-meshheading:12352386-Cyclic Nucleotide Phosphodiesterases, Type 5
,
pubmed-meshheading:12352386-Dose-Response Relationship, Drug
,
pubmed-meshheading:12352386-Double-Blind Method
,
pubmed-meshheading:12352386-Erectile Dysfunction
,
pubmed-meshheading:12352386-Humans
,
pubmed-meshheading:12352386-Male
,
pubmed-meshheading:12352386-Middle Aged
,
pubmed-meshheading:12352386-Phosphodiesterase Inhibitors
,
pubmed-meshheading:12352386-Phosphoric Diester Hydrolases
,
pubmed-meshheading:12352386-Treatment Outcome
pubmed:year
2002
pubmed:articleTitle
Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses.
pubmed:affiliation
Department of Surgery, Division of Urology, Faculty of Medicine and Dentistry, University of Western Ontario, London, Canada.
pubmed:publicationType
Clinical Trial
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't